ECGs can now be taken anywhere
Taking 12-channel cardiac ultrasounds (ECGs) is currently a time-consuming and complex process that requires trained professionals. HeartEye ensures that these heart films can be taken quickly, easily and anywhere. Their innovation supports GP practices and nursing homes in performing cardiac diagnostics and, in time, patients can do it themselves at home. HeartEye's fully wireless ECG recorder is handy and user-friendly. In less than a minute, a GP, assistant or nurse makes a 12-channel ECG. Via the digital platform, the heart film can be shared with a doctor or specialist to request support in interpretation and diagnosis. This unique ECG recorder makes it easier to perform professional, high-quality cardiac diagnostics outside the hospital. On the one hand, it detects heart problems earlier, enabling the right patients to reach the cardiologist in time. On the other hand, it prevents unnecessary referrals to the hospital. This contributes to more efficient care, lower costs and less workload.
This is what HeartEye will do with the capital
Like other MedTech innovations, HeartEye has to set up a manufacturing process and certify it according to the applicable laws and regulations (MDR). This is a time- and capital-intensive period. At this stage, the product may not yet be used clinically and thus no regular sales can be generated, but a company has to make significant investments. That is where this investment helps. With the capital injection of €1,675,000, HeartEye is, among other things, conducting the pitoval clinical trial and working on the further development of the AI software. In addition, HeartEye is working on the further development of the digital healthcare platform and is ramping up production capacity to meet expected demand after market approval.
This is why ROM InWest is participating
ROM InWest sees it as its role to HeartEye through this phase, partly because Venture Capital parties usually get in before developing a prototype, or only after CE certification and market launch, when the technological and market-related risk has been significantly reduced and scale-up can take place. With its innovative ECG recorder, HeartEye is making an immediate and sustainable contribution to the future-proofing and affordability of healthcare. We foresee that HeartEye thus has substantial opportunities to grow into a leading player that stimulates high-quality employment and knowledge development in the region.
